To investigate whether Hpl is sufficient for enhanced defense against NTHi colonization and infection, mice were treated with 1, 10, or 100 μg of recombinant Hpl (rHpl) prior to NTHi infection (Fig. 4A). This evidence concerns the gene LGALS1 and infection.